ປະຫວັດການກວດເລືອດ: ຕິດຕາມຜົນການກວດທາງຫ້ອງທົດລອງແຕ່ລະປີ

ໝວດໝູ່
ບົດຄວາມ
ສຸຂະພາບປ້ອງກັນ ການອ່ານຜົນກວດເລືອດ ການອັບເດດ 2026 ສຳລັບຄົນເຈັບ

A single normal result can miss the story. The better view is your baseline, your rate of change, and whether several markers drift together.

📖 ~12 ນາທີ 📅
📝 ຈັດພິ. I need to provide translations for all items; continue. 🩺 Medically Reviewed: ✅ ອີງຕາມຫຼັກຖານ
⚡ ສະຫຼຸບໂດຍຫຍໍ້ v1.0 —
  1. A1c drift of 0.3-0.4% in a year is usually more meaningful than a 0.1% wobble.
  2. eGFR below 60 mL/min/1.73 m² for at least 3 months suggests chronic kidney disease.
  3. ເຟີຣິຕິນ below 30 ng/mL often points to iron deficiency; below 15 ng/mL is highly specific.
  4. ວິຕາມິນ D below 20 ng/mL is deficiency, while 20-29 ng/mL is commonly called insufficiency.
  5. B12 below 200 pg/mL is low in most labs; 200-300 pg/mL is borderline and needs context.
  6. hs-CRP under 1 mg/L is low risk, 1-3 mg/L average, and above 3 mg/L higher risk if you are otherwise well.
  7. ກວດທົບທວນດ່ວນ is sensible for potassium below 3.0 or above 6.0 mmol/L, or AST/ALT above 3× the upper limit.
  8. ກົດເກນແນວໂນ້ມ (Trend rule): compare the same lab, same fasting state, same time of day, and the same supplement list.

Why a blood test history matters more than one normal result

ຄູ່ມືທີ່ເປັນປະໂຫຍດ ປະຫວັດການກວດເລືອດ is a dated timeline of the same biomarkers, collected under similar conditions, compared against your own baseline rather than the lab flag alone. The patterns that matter often appear before a result turns abnormal: HbA1c rising from 5.2% to 5.8%, eGFR slipping from 96 to 74 mL/min/1.73 m², or ALT moving from 16 to 32 IU/L can matter even while the report still looks fine. On Kantesti AI, we tell patients to track 8-12 core markers yearly and trust persistent direction more than a single isolated blip.

Sequential yearly lab samples arranged as a personal timeline for result comparison
ຮູບທີ 1: A personal lab timeline shows how small changes become visible when several years are viewed together.

The thing is, the lab range is built from population data, not from you. Your own baseline is often narrower, which is why a quiet 15-20% shift can matter before a flag appears; our ຄູ່ມືພື້ນຖານສ່ວນຕົວຂອງທ່ານ explains why slope often beats snapshot.

Last month I reviewed a 41-year-old man's results: A1c 5.2%, 5.4%, 5.6%, then 5.8% over four annual checkups. No single report looked dramatic, but the combined drift in triglycerides from 118 to 196 mg/dL and ALT from 17 to 33 IU/L told us far more than the report colors did.

As Thomas Klein, MD, I spend far more time on slopes than snapshots. In our analysis of uploaded panels across more than 2M users, single-marker blips are common, but same-direction movement in 2 or 3 related markers is where preventive medicine actually gets traction.

How to build a personal lab timeline in one afternoon

You can build a usable timeline in 60-90 minutes. Start with the last 5 years if you have them, then record the test date, lab name, fasting status, collection time, recent illness, hard exercise in the prior 72 hours, new supplements, and any medication change.

Patient organizing past laboratory reports into a dated tracking system
ຮູບທີ 2: Good trend analysis starts with clean records, dates, units, and the context around each test.

Begin with the original source documents, not a remembered summary. Patient portals often hide older results or strip out the original units, so pull the PDFs or scan the printed reports; our results access guide is useful if you are digging through multiple hospital systems.

Use the cleanest copy you have. A straight, well-lit scan or phone photo is usually enough for our ເພາະວ່າຫ້ອງທົດລອງປະສົມ, but I still prefer the original PDF when possible because the reference interval and methodology are less likely to be cut off.

Record the units exactly as shown. A fasting glucose of 5.6 mmol/L is not the same visual scale as 101 mg/dL, and small mistakes like that wreck blood test trend analysis faster than most patients realize.

Add a tiny notes column. Biotin 5-10 mg, a viral illness, heavy dehydration, new statin therapy, or a half marathon 24 hours before the draw can explain a surprising amount of apparent noise.

What to write beside each result

My short list is date, time, lab, fasting or not, major exercise within 72 hours, alcohol the night before, supplements, menstrual cycle day when relevant, and new medication starts. When that context is present, track blood test results becomes a clinical exercise instead of guesswork.

What change is real and what is just lab noise?

Most year-to-year variation is not disease. For common markers, a change becomes more believable when it exceeds ordinary biological and analytical variation and then shows up again on a repeat test under similar conditions.

Side-by-side comparison of stable versus noisy laboratory variation patterns
ຮູບທີ 3: Some movement is expected; the trick is knowing when a shift is larger than normal variation.

Real change usually exceeds both analytical variation and ordinary day-to-day biology. For HbA1c, a year-over-year rise of 0.3-0.4% is usually more meaningful than a wiggle of 0.1%; our ການປຽບທຽບແນວໂນ້ມໃນບົດຄວາມ walks through why that matters in practice.

Some markers are inherently twitchy. TSH may vary 30-50% between early morning and later draws, triglycerides can swing 20-30% after alcohol or a late meal, and biotin doses of 5-10 mg can distort some thyroid immunoassays, a trap we cover in our biotin interference article.

I use a simple three-part filter: same lab if possible, same collection window, same pre-test conditions. If those line up and the marker moves twice in the same direction, I treat it as signal until proven otherwise.

Which biomarkers are actually worth tracking for years

For most adults, the long-term keepers are CBC, HbA1c or fasting glucose, ກະດານ lipid, creatinine/eGFR, ALT/AST, and selected add-ons such as ເຟີຣິຕິນ, ວິຕາມິນ D, B12, ຫຼື TSH when risk or symptoms justify them.

Core biomarker groups grouped for long-term preventive tracking
ຮູບທີ 4: A practical timeline focuses on a handful of high-yield markers rather than an oversized panel.

A smart ການກວດເລືອດເພື່ອປ້ອງກັນ should answer one of three questions: am I drifting toward cardiometabolic disease, am I missing a deficiency, or am I quietly losing kidney or liver reserve. If a marker rarely changes management, it probably does not belong in everybody's yearly panel; our 15,000-marker biomarker guide helps sort high-yield from low-yield testing.

That is why we do not tell every healthy 28-year-old to chase 40 hormones and tumor markers. In my experience, broad untargeted panels create false alarms faster than insight, and our ການທົບທວນການກວດເລືອດມາດຕະຖານ shows where routine panels help and where they simply distract.

A marker earns a place on your timeline if three things are true: it changes meaningfully over time, you can act on it, and it makes sense next to another marker. HbA1c, LDL-C, eGFR, hemoglobin, ແລະ ALT fit that rule beautifully.

What usually does not belong in a yearly timeline without a reason

Random tumor markers, cortisol, broad autoimmune screening, and niche hormones are poor default trackers for low-risk people. They have uses, of course, but a long-term timeline works best when every dot has a real decision attached to it.

CBC, iron, B12, vitamin D, and inflammation markers worth the long game

For deficiencies and low-grade inflammation, the best long-term markers are hemoglobin/CBC, ເຟີຣິຕິນ, B12, 25-OH ວິຕາມິນດີ, ແລະບາງຄັ້ງ hs-CRP. A ferritin below 30 ng/mL often suggests iron deficiency, a B12 below 200 pg/mL is low in most labs, and 25-OH vitamin D below 20 ng/mL indicates deficiency.

CBC, ferritin, B12, vitamin D, and hs-CRP shown as serial wellness markers
ຮູບທີ 7: Deficiency markers often drift gradually, making a timeline more useful than a one-off result.

Early iron depletion often shows up as falling ເຟີຣິຕິນ first, then rising RDW, then lower MCV, and only later a low hemoglobin. A ferritin under 15 ng/mL is highly specific for iron deficiency, but in everyday practice I worry once it drops below 30 ng/mL, especially if symptoms are present; our ຄູ່ມືຊ່ວງ ferritin covers the nuance well.

B12 tends to fall slowly, particularly with metformin, acid-suppressing medication, vegan diets, ileal disease, and aging. Our B12 range article is useful for borderline results, and our ລະດັບວິຕາມິນດີ ແມ່ນຕົວຊີ້ນຳ explains why Holick and the Endocrine Society defined deficiency as under 20 ng/mL and insufficiency as 21-29 ng/mL, although many clinicians are comfortable once patients are above 30 ng/mL unless bone disease or malabsorption is in the picture (Holick et al., 2011).

High-sensitivity ຄໍຣັບຊັນຊີພີ is one of those markers that is informative only when the patient is otherwise well. hs-CRP under 1 mg/L is low cardiovascular risk, 1-3 mg/L average, above 3 mg/L higher risk if there is no acute illness, and more than 10 mg/L usually means you should repeat it after the cold, dental flare, or inflammatory event has settled.

Low Background Inflammation <1.0 ມກ/ລິດ Lower cardiovascular risk when measured in a well state
Average Risk Range 1.0-3.0 mg/L Common in adults; interpret alongside weight, smoking, and metabolic risk
Persistently High 3.1-10.0 mg/L Higher cardiovascular or inflammatory burden if repeat results stay elevated
Acute Inflammation Likely >10.0 mg/L Often reflects infection, injury, or major inflammation; repeat when well

A quiet CBC clue I see early

A hemoglobin drop of more than 1 g/dL over a year deserves an explanation even if the report still says normal. When hemoglobin falls together with rising RDW and drifting ferritin, the body is often telling the story before symptoms become obvious.

How often should you repeat a preventive blood test?

Most healthy adults do not need monthly labs. A reasonable ການກວດເລືອດເພື່ອປ້ອງກັນ rhythm is every 12-24 months if you are low risk, yearly if you have family history or previous drift, and every 3-6 months when a clinician is actively monitoring a change.

Different life stages matched to sensible repeat testing intervals
ຮູບທີ 8: Repeat frequency should reflect risk, age, symptoms, and the direction of prior results.

Age changes the calculus. Women in their 30s often benefit from periodic iron, thyroid, and glucose review if fatigue, heavy periods, pregnancy planning, or postpartum recovery enter the picture; our ກວດກາເຊັກລິສສຳລັບຜູ້ຍິງໃນອາຍຸ 30 ປີ (women in their 30s checklist) is built around those real-world scenarios.

Men over 50 deserve closer tracking of lipids, glucose, kidney function, CBC, and sometimes PSA depending on shared decision-making. I usually shorten the interval to 6-12 months if A1c is 5.8-6.3%, LDL keeps rising despite lifestyle work, or eGFR has fallen more than 10-15 points from prior baseline; our men over 50 testing guide gives a sensible framework.

Diet patterns matter too. Vegans may need yearly B12, ferritin, vitamin D, and sometimes iron studies, which is why our vegan routine blood test article has become one of the pages I send most often to patients.

Intervals I shorten without hesitation

Prediabetes, a new statin or thyroid dose, recent iron replacement, a falling eGFR, unexplained weight loss, or a family history of premature cardiovascular disease all move me toward 3-6 month rechecks. Stable low-risk patients with boring labs are allowed to stay boring, and that is usually good news.

How Kantesti helps you track blood test results safely

A good trend tool does more than store PDFs. It should normalize units, line up dates, recognize fasting status, flag likely confounders, and show whether several biomarkers are moving together; that is exactly how Kantesti approaches blood test trend analysis.

AI-assisted blood test trend analysis with normalized data from multiple reports
ຮູບທີ 9: The real value of AI is not storage alone; it is standardization, context checking, and pattern recognition.

ໃນ Kantesti, patients upload a PDF or phone photo and our system extracts analytes, units, dates, and reference intervals in about 60 seconds. That sounds simple until you have seen how often one lab reports creatinine in mg/dL, another pairs it with eGFR only, and an older portal drops the original range altogether.

Our organization details are public on ກ່ຽວກັບພວກເຮົາ. The physician oversight behind our interpretations is listed on the ຄະນະທີ່ປຶກສາທາງການແພດ, because in medicine a trend tool should show its human supervision, not hide it.

Accuracy matters more than pretty graphics. Our ການກວດສອບທາງການແພດ page explains the clinical standards behind unit normalization and OCR error checking, and our ຄູ່ມືດ້ານເທັກໂນໂລຍີ shows how Kantesti's neural network compares linked markers across chemistry, hematology, and nutritional panels.

As of April 18, 2026, Kantesti serves more than 2M users across 127+ countries and 75+ languages. We are CE marked, HIPAA and GDPR aligned, ISO 27001 certified, and in day-to-day use the feature patients mention most is surprisingly plain: a note that says a result is still within range but has moved 22% from baseline twice in the same direction.

ບົດຄົ້ນຄວ້າ ແລະການອ່ານເພີ່ມເຕີມທີ່ເລິກກວ່າ

Research publications help when you want to go beyond a routine printout. We keep a short reading list for patients who like mechanism, especially around hematology patterns and the way symptoms can distort interpretation.

Medical research papers paired with advanced hematology and laboratory markers
ຮູບທີ 11: Deeper reading can help motivated patients understand why some trends matter before a diagnosis is obvious.

If your timeline includes anemia recovery, unexplained fatigue, rising LDH, or a changing reticulocyte count, our ຄູ່ມືເຄື່ອງໝາຍເລືອດວິທະຍາ is the place I would start. Reticulocytes often rise before hemoglobin fully recovers, which means the story can improve on paper even while the absolute hemoglobin still looks discouraging.

GI symptoms matter more than people expect when they are reading long-term labs. Diarrhea after fasting, stool changes, dehydration, and short-term inflammation can all nudge creatinine, BUN, ferritin, and CRP in ways that look more sinister than they really are if the clinical context is missing.

I keep the two formal DOI references below because they are practical, not theoretical. They are the kind of reads that help you understand why a lab trend needs context, timing, and a bit of humility.

ຄໍາຖາມທີ່ຖາມເລື້ອຍໆ

ຂ້ອຍຄວນເກັບຮັກສາຜົນກວດເລືອດໄວ້ຈັກປີ?

ພະຍາຍາມເກັບຮັກສາຜົນໄວ້ຢ່າງນ້ອຍ 5 ປີ ຖ້າເຮັດໄດ້ ແລະ ດົນກວ່າຍິ່ງດີສຳລັບຕົວຊີ້ວັດທີ່ຄ່ອຍໆປ່ຽນໄປ ເຊັ່ນ A1c, LDL-C, ferritin, TSH, creatinine, ແລະ ວິຕາມິນດີ. ໃນການປະຕິບັດ ຜົນປະຈຳປີ 2-3 ຄັ້ງກໍສາມາດບອກເສັ້ນໂນ້ມທີ່ເປັນປະໂຫຍດໄດ້ ແຕ່ 5 ປີຈະໃຫ້ຄວາມເຂົ້າໃຈທີ່ຊັດເຈນກວ່າຫຼາຍກ່ຽວກັບຄ່າພື້ນຖານ ແລະ ທິດທາງ. ຂ້ອຍແນະນຳຄົນເຈັບສ່ວນໃຫຍ່ໃຫ້ເກັບ PDF ຕົ້ນສະບັບ ບໍ່ແມ່ນແຕ່ເອົາພາບໜ້າຈໍຈາກພອດທັນ (portal screenshot) ເພາະວ່າ ໜ່ວຍ ແລະ ຊ່ວງອ້າງອີງມັກຈະຫາຍໄປໃນສະຫຼຸບ.

ອັນໃດຖືກນັບວ່າເປັນການປ່ຽນແປງທີ່ມີຄວາມໝາຍ ຖ້າວ່າຜົນຂອງຂ້ອຍຍັງຢູ່ໃນລະດັບປົກກະຕິ?

ການປ່ຽນແປງທີ່ມີຄວາມໝາຍຂຶ້ນກັບຕົວຊີ້ວັດ (biomarker) ແຕ່ວ່າມີບາງທາງລັດທີ່ເປັນປະໂຫຍດ. ການເພີ່ມຂຶ້ນຂອງ A1c 0.3-0.4% ໃນ 1 ປີ, ການເພີ່ມຂຶ້ນຂອງ creatinine 0.3 mg/dL, ການຫຼຸດລົງຂອງ eGFR ຫຼາຍກວ່າ 10-15 mL/min/1.73 m², ການຫຼຸດລົງຂອງ hemoglobin 1 g/dL, ຫຼື ferritin ທີ່ຫຼຸດລົງຕ່ຳກວ່າ 30 ng/mL ປົກກະຕິແລ້ວຄວນໃຫ້ຄວາມສົນໃຈ ເຖິງແມ່ນວ່າຫ້ອງທົດລອງບໍ່ໄດ້ສະແດງສັນຍານ. ຂ້ອຍເຊື່ອການປ່ຽນແປງຫຼາຍຂຶ້ນ ເມື່ອມັນຖືກຢືນຢັນຊ້ຳພາຍໃຕ້ເງື່ອນໄຂຄ້າຍຄືກັນ ແລະ ຂະຫຍາຍໄປໃນທິດທາງດຽວກັນສອງຄັ້ງ.

ຂ້ອຍສາມາດປຽບທຽບຜົນກວດເລືອດຈາກຫ້ອງທົດລອງຕ່າງກັນໄດ້ບໍ?

ແມ່ນແຕ່ຄວນປຽບທຽບຢ່າງລະມັດລະວັງ. ທົດລອງແຕ່ລະແຫ່ງອາດໃຊ້ໜ່ວຍວັດແທກ, ວິທີການທົດສອບ (assay), ແລະຊ່ວງອ້າງອີງ (reference intervals) ທີ່ບໍ່ຄືກັນ, ດັ່ງນັ້ນ mg/dL ທຽບກັບ mmol/L ຫຼືການປ່ຽນເຄື່ອງວິເຄາະ (analyzer) ອາດເຮັດໃຫ້ການປ່ຽນແປງທີ່ປົກກະຕິເບິ່ງຄືວ່າຮຸນແຮງ. ການປຽບທຽບທີ່ປອດໄພທີ່ສຸດແມ່ນໃຊ້ຫ້ອງທົດລອງດຽວກັນ, ເວລາເກັບຕົວຢ່າງດຽວກັນ, ສະຖານະການງົດອາຫານ (fasting) ດຽວກັນ, ແລະລາຍຊື່ອາຫານເສີມ (supplement) ດຽວກັນ; ຖ້າບໍ່ສາມາດເຮັດໄດ້, ໃຫ້ຈົດບັນທຶກຊື່ຫ້ອງທົດລອງ ແລະວິທີການ (method) ຂ້າງເລກຜົນດັ່ງກ່າວ.

ຕົວຊີ້ວັດເລືອດອັນໃດທີ່ຄວນຕິດຕາມເປັນປະຈຳທຸກໆປີຫຼາຍທີ່ສຸດ?

ສຳລັບຜູ້ໃຫຍ່ສ່ວນໃຫຍ່, ຕົວຊີ້ວັດປະຈຳປີທີ່ໃຫ້ຜົນຄຸ້ມຄ່າສູງສຸດແມ່ນ ການກວດເລືອດຄົບຖ້ວນ, A1c ຫຼື ນ້ຳຕານໃນເລືອດຂະໜາດກາງ (fasting glucose), ກະດານໄຂມັນ (lipid panel), creatinine ພ້ອມກັບ eGFR, ແລະ ເອນໄຊຕັບເຊັ່ນ ALT ແລະ AST. Ferritin, B12, ຂາດວິຕາມິນດີ, TSH, ແລະ hs-CRP ສາມາດເປັນຕົວເສີມທີ່ດີຫຼາຍ ເມື່ອອາການ, ອາຫານ, ຢາ, ປະຫວັດສຸຂະພາບຄອບຄົວ, ຫຼື ຜົນກ່ອນໜ້າ ມີເຫດຜົນຮອງຮັບ. ກຸ່ມກວດຮໍໂມນທີ່ກວ້າງຫຼາຍ ແລະ ຕົວຊີ້ວັດມະເຮັງສຸ່ມ (random tumor markers) ມັກຈະມີຄ່າຕ່ຳສຳລັບການຕິດຕາມລະຍະຍາວປະຈຳໃນຄົນທີ່ມີສຸຂະພາບດີ.

ຜູ້ໃຫຍ່ທີ່ມີສຸຂະພາບດີຄວນໄດ້ຮັບການກວດເລືອດເພື່ອປ້ອງກັນພະຍາດເລື້ອຍປານໃດ?

ຜູ້ໃຫຍ່ທີ່ມີຄວາມສ່ຽງຕໍ່າ ແລະມີສຸຂະພາບດີ ມັກຈະເໝາະກັບການກວດທຸກ 12-24 ເດືອນ ຫຼາຍກວ່າການກວດທຸກໆສອງສາມເດືອນ. ການກວດປະຈຳປີ ມີເຫດຜົນ ເມື່ອມີປະຫວັດສຸຂະພາບຄອບຄົວ, ນ້ຳໜັກເພີ່ມຂຶ້ນ, ໂລກຄວາມດັນເລືອດສູງ, ການໃຊ້ຢາ, ການກິນອາຫານແບບວິທະຍານ (vegan), ການວາງແຜນຖືພາ, ຫຼືມີການປ່ຽນແປງກ່ອນໜ້າໃນ A1c, LDL-C, ferritin, ຫຼືຕົວຊີ້ວັດໝາຍຂອງໝາກໄຂ່ຫຼັງ. ເມື່ອຜົນເລີ່ມຂະຍາຍຕົວ ການກວດຊ້ຳທຸກ 3-6 ເດືອນ ມັກຈະເປັນປະໂຫຍດຫຼາຍກວ່າການລໍຖ້າອີກໜຶ່ງປີເຕັມ.

ປັນຍາປະດິດ (AI) ຊ່ວຍຂ້ອຍຕິດຕາມຜົນກວດເລືອດຈາກ PDF ແລະຮູບຖ່າຍໄດ້ບໍ?

ແມ່ນ, ຖ້າລະບົບມີການເຮັດຫຼາຍກວ່າ OCR ພື້ນຖານ. ເຄື່ອງມືທີ່ເປັນປະໂຫຍດຄວນສາມາດດຶງວັນທີ ແລະ ໜ່ວຍໄດ້, ປັບແປງ mmol/L ແລະ mg/dL ໃຫ້ຖືກຕ້ອງ, ຮັກສາຊ່ວງອ້າງອີງເດີມໄວ້, ແລະ ປຽບທຽບຕົວຊີ້ວັດຫຼາຍຢ່າງພ້ອມກັນ ແທນທີ່ຈະປຽບທຽບແຕ່ລະຢ່າງຄັ້ງດຽວ. ຢູ່ Kantesti, ການອັບໂຫຼດສ່ວນໃຫຍ່ຖືກປະມວນຜົນໃນປະມານ 60 ວິນາທີ, ແລະ ຜົນລັບຈະເປັນປະໂຫຍດຫຼາຍທີ່ສຸດ ເມື່ອຄົນເຈັບຍັງເພີ່ມບໍລິບົດທີ່ໃບລາຍງານຫ້ອງທົດລອງບໍ່ສາມາດຈັບໄດ້ດີ, ເຊັ່ນ ພະຍາດ, ອາຫານເສີມ, ພາລະການຝຶກ, ແລະ ສະຖານະການຖືກອົດອາຫານ.

ຂ້ອຍຄວນກັງວົນເມື່ອໃດກ່ຽວກັບແນວໂນ້ມຂອງຜົນກວດໃນທັນທີ?

ຄວນກັງວົນໄວຂຶ້ນເມື່ອຕົວເລກຖືກຄູ່ກັບອາການ ຫຼື ຂ້າມຂອບເຂດທີ່ສາມາດກາຍເປັນອັນຕະລາຍໄດ້ຢ່າງໄວ. ໂພແທດຊຽມຕໍ່າກວ່າ 3.0 ຫຼື ສູງກວ່າ 6.0 mmol/L, ນ້ຳຕານສູງກວ່າ 200 mg/dL ພ້ອມອາການ, creatinine ເພີ່ມຂຶ້ນ 0.3 mg/dL ໃນ 48 ຊົ່ວໂມງ, ເກັດເລືອດຕໍ່າກວ່າ 100 ×10⁹/L, ຫຼື AST/ALT ສູງກວ່າ 3 ເທົ່າຂອບເທິງຄວນບໍ່ລໍຖ້າການທົບທວນປະຈຳປີຄັ້ງຕໍ່ໄປ. ການຈັດເວລາແມ່ນຊ່ວຍໄດ້, ແຕ່ສະພາບທາງສະຫຼຸບທີ່ຮີບດ່ວນຍັງສຳຄັນກວ່າການວິເຄາະແນວໂນ້ມ.

ຮັບການວິເຄາະຜົນກວດເລືອດດ້ວຍ AI ທັນທີ

ເຂົ້າຮ່ວມຜູ້ໃຊ້ຫຼາຍກວ່າ 2 ລ້ານຄົນທົ່ວໂລກ ທີ່ໄວ້ໃຈ Kantesti ສຳລັບການວິເຄາະການກວດເລືອດທີ່ທັນທີ ແລະຖືກຕ້ອງ. ອັບໂຫຼດຜົນກວດເລືອດຂອງທ່ານ ແລະຮັບການຕີຄວາມໝາຍຢ່າງຄົບຖ້ວນຂອງ biomarker 15,000+ ໃນວິນາທີ.

📚 ບົດຄວາມວິຈັຍທີ່ອ້າງອີງ

1

Klein, T., Mitchell, S., & Weber, H. (2026). ຄູ່ມືປະເພດເລືອດ B ລົບ, ການກວດເລືອດ LDH ແລະຈຳນວນເມັດເລືອດແດງອ່ອນ (Reticulocyte Count). ການຄົ້ນຄວ້າທາງການແພດຂອງ AI Kantesti.

2

Klein, T., Mitchell, S., & Weber, H. (2026). ຖອກທ້ອງຫຼັງຈາກອົດອາຫານ, ມີຈຸດດຳໃນອາຈົມ ແລະ ຄູ່ມືກ່ຽວກັບລະບົບຍ່ອຍອາຫານ ປີ 2026. ການຄົ້ນຄວ້າທາງການແພດຂອງ AI Kantesti.

📖 ເອກະສານອ້າງອີງທາງການແພດພາຍນອກ

3

Grundy SM et al. (2019). ຄູ່ມື 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA ວ່າດ້ວຍການຈັດການໄຂມັນໃນເລືອດ. Circulation.

4

Inker LA et al. (2021). ສົມຜົນໃໝ່ສຳລັບ Creatinine ແລະ Cystatin C ເພື່ອປະເມີນ GFR ໂດຍບໍ່ໃຊ້ເຊື້ອຊາດ. ວາລະສານການແພດແຫ່ງຊາດສະຫະລັດ New England Journal of Medicine.

5

Holick MF ແລະຄະນະ (2011). ການປະເມີນ, ການຮັກສາ, ແລະ ການປ້ອງກັນການຂາດວິຕາມິນດີ: ຄູ່ມືທາງຄລີນິກຂອງ Endocrine Society. ວາລະສານ Journal of Clinical Endocrinology & Metabolism.

2 ລ້ານ+ການ​ທົດ​ສອບ​ການ​ວິ​ເຄາະ​
127+ປະເທດ
98.4%ຄວາມຖືກຕ້ອງ
75+ພາສາ

⚕️ ຂໍ້ສັງເກດທາງການແພດ

ສັນຍານຄວາມໄວ້ໃຈ E-E-A-T

ປະສົບການ

ການທົບທວນຄລີນິກຂອງແພດຜູ້ນຳພາ ກ່ຽວກັບຂັ້ນຕອນການຕີຄວາມໝາຍຜົນການກວດໃນຫ້ອງທົດລອງ.

📋

ຄວາມຊ່ຽວຊານ

ວິຊາການແພດທົດລອງ (ການແພດທາງຫ້ອງທົດລອງ) ເນັ້ນໃສ່ວ່າຕົວຊີ້ວັດ (biomarkers) ມີພຶດຕິກຳແນວໃດໃນບັນບົດທາງຄລີນິກ.

👤

ຄວາມເປັນອຳນາດ

ຂຽນໂດຍທ່ານດຣ. Thomas Klein ໂດຍມີການກວດທານໂດຍທ່ານດຣ. Sarah Mitchell ແລະ ສາດສະດາຈານດຣ. Hans Weber.

🛡️

ຄວາມໜ້າເຊື່ອຖື

ການຕີຄວາມໝາຍອີງຕາມຫຼັກຖານດ້ວຍເສັ້ນທາງຕິດຕາມທີ່ຊັດເຈນ ເພື່ອຫຼຸດການຕົກໃຈ.

🏢 ບໍລິສັດ ແຄນເທສຕິ ຈຳກັດ ຈົດທະບຽນໃນປະເທດອັງກິດ ແລະ ເວວສ໌ · ເລກທີບໍລິສັດ No. 17090423 ລອນດອນ, ສະຫະລາຊະອານາຈັກ · kantesti.net
blank
ໂດຍ Prof. Dr. Thomas Klein

ດຣ. ທອມັສ ໄຄລນ໌ (Thomas Klein) ເປັນນັກວິທະຍາສາດດ້ານເລືອດວິທະຍາທາງດ້ານການແພດທີ່ໄດ້ຮັບການຮັບຮອງຈາກຄະນະກຳມະການ ເຊິ່ງເຮັດໜ້າທີ່ເປັນຫົວໜ້າເຈົ້າໜ້າທີ່ແພດທີ່ Kantesti AI. ດ້ວຍປະສົບການຫຼາຍກວ່າ 15 ປີໃນດ້ານການແພດໃນຫ້ອງທົດລອງ ແລະ ຄວາມຊ່ຽວຊານຢ່າງເລິກເຊິ່ງໃນການວິນິດໄສດ້ວຍ AI, ດຣ. ໄຄລນ໌ ໄດ້ເຊື່ອມຕໍ່ຊ່ອງຫວ່າງລະຫວ່າງເຕັກໂນໂລຢີທີ່ທັນສະໄໝ ແລະ ການປະຕິບັດທາງດ້ານການແພດ. ການຄົ້ນຄວ້າຂອງລາວແມ່ນສຸມໃສ່ການວິເຄາະເຄື່ອງໝາຍຊີວະພາບ, ລະບົບສະໜັບສະໜູນການຕັດສິນໃຈທາງດ້ານການແພດ, ແລະ ການເພີ່ມປະສິດທິພາບຂອງຂອບເຂດອ້າງອີງສະເພາະປະຊາກອນ. ໃນຖານະເປັນ CMO, ລາວນຳພາການສຶກສາການຢັ້ງຢືນແບບ triple-blind ທີ່ຮັບປະກັນວ່າ AI ຂອງ Kantesti ບັນລຸຄວາມຖືກຕ້ອງ 98.7% ໃນກໍລະນີທົດສອບທີ່ຖືກຢືນຢັນຫຼາຍກວ່າ 1 ລ້ານກໍລະນີຈາກ 197 ປະເທດ.

ຕອບກັບ

ເມວຂອງທ່ານຈະບໍ່ຖືກເຜີຍແຜ່ໃຫ້ໃຜຮູ້ ບ່ອນທີ່ຕ້ອງການແມ່ນຖືກຫມາຍໄວ້ *